本頁面由Tiger Trade Technology Pte. Ltd.提供服務

BridgeBio Pharma, Inc.

67.97
-4.4100-6.09%
成交量:232.06萬
成交額:1.60億
市值:133.09億
市盈率:-19.05
高:72.41
開:72.26
低:66.96
收:72.38
52周最高:93.42
52周最低:48.78
股本:1.96億
流通股本:1.67億
量比:1.35
換手率:1.39%
股息:- -
股息率:- -
每股收益(TTM):-3.5686
每股收益(LYR):-3.7850
淨資產收益率:-1789.67%
總資產收益率:-26.00%
市淨率:-5.29
市盈率(LYR):-17.96

資料載入中...

2026/06/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/29

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/27

重要事件披露

Form 8-K - Current report
2026/05/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/13

重要事件披露

Form 8-K - Current report
2026/05/08

重要事件披露

Form 8-K - Current report
2026/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/07

重要事件披露

Form 8-K - Current report
2026/04/16

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/31

重要事件披露

Form 8-K - Current report
2026/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/24

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/24

重要事件披露

Form 8-K - Current report
2026/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities